CATALOGO DEI PRODOTTI DELLA RICERCA

ZIPETO, Donato
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.431
EU - Europa 10.115
AS - Asia 9.929
SA - Sud America 1.002
Continente sconosciuto - Info sul continente non disponibili 228
AF - Africa 196
OC - Oceania 39
Totale 32.940
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.148
CN - Cina 4.425
RU - Federazione Russa 3.401
SG - Singapore 3.177
GB - Regno Unito 2.409
IT - Italia 1.224
BR - Brasile 807
VN - Vietnam 796
HK - Hong Kong 627
FR - Francia 587
DE - Germania 528
SE - Svezia 485
IE - Irlanda 476
FI - Finlandia 454
KR - Corea 274
UA - Ucraina 170
CA - Canada 162
IN - India 115
ID - Indonesia 83
NG - Nigeria 76
BD - Bangladesh 75
AR - Argentina 70
NL - Olanda 68
BE - Belgio 64
MX - Messico 64
TR - Turchia 63
JP - Giappone 53
PL - Polonia 44
IQ - Iraq 42
ZA - Sudafrica 41
AU - Australia 37
EC - Ecuador 34
ES - Italia 32
AT - Austria 31
LT - Lituania 28
UZ - Uzbekistan 23
PK - Pakistan 22
CO - Colombia 18
JO - Giordania 18
SA - Arabia Saudita 17
CL - Cile 16
RO - Romania 16
AE - Emirati Arabi Uniti 14
PY - Paraguay 14
VE - Venezuela 13
IR - Iran 12
MA - Marocco 12
PE - Perù 12
PH - Filippine 12
CH - Svizzera 11
CR - Costa Rica 11
AZ - Azerbaigian 10
EG - Egitto 10
KE - Kenya 10
BO - Bolivia 9
IL - Israele 9
TN - Tunisia 9
JM - Giamaica 8
KZ - Kazakistan 8
NO - Norvegia 8
NP - Nepal 8
SI - Slovenia 8
TG - Togo 8
UY - Uruguay 8
BG - Bulgaria 7
DK - Danimarca 7
LB - Libano 7
AL - Albania 6
CZ - Repubblica Ceca 6
HU - Ungheria 6
OM - Oman 6
SV - El Salvador 6
BJ - Benin 5
DZ - Algeria 5
ET - Etiopia 5
EU - Europa 5
HN - Honduras 5
LV - Lettonia 5
MY - Malesia 5
NI - Nicaragua 5
SN - Senegal 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
GR - Grecia 4
KG - Kirghizistan 4
PA - Panama 4
PS - Palestinian Territory 4
PT - Portogallo 4
DO - Repubblica Dominicana 3
HR - Croazia 3
TW - Taiwan 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
EE - Estonia 2
GT - Guatemala 2
IS - Islanda 2
LK - Sri Lanka 2
LU - Lussemburgo 2
Totale 32.679
Salva come PNG Salva come JPEG
Città #
Southend 2.051
Singapore 1.700
Jacksonville 1.308
Moscow 1.121
Chandler 1.066
San Jose 1.044
Ashburn 1.010
Dallas 920
Verona 659
Hong Kong 615
Ann Arbor 481
Dublin 474
Woodbridge 456
Council Bluffs 449
Beijing 381
Houston 338
The Dalles 271
Ho Chi Minh City 245
New York 245
Los Angeles 194
Wilmington 193
Lawrence 185
Princeton 185
Nanjing 184
Hanoi 144
Jinan 137
Helsinki 127
Shenyang 115
Tianjin 98
Buffalo 97
Sindelfingen 90
Munich 89
São Paulo 82
Milan 81
Changsha 77
Dong Ket 74
Abuja 73
Boardman 73
Santa Clara 73
Hebei 72
Orem 68
Nanchang 65
Ningbo 62
Redondo Beach 62
Seattle 62
Haikou 61
Zhengzhou 60
Hangzhou 58
Brussels 56
Jakarta 56
Columbus 55
Montreal 53
London 51
Redmond 45
Atlanta 44
Da Nang 43
Seoul 43
Taizhou 43
Frankfurt am Main 42
Tokyo 42
Jiaxing 41
Cambridge 40
Guangzhou 40
Toronto 39
Lancaster 36
Warsaw 36
Taiyuan 34
Denver 32
Haiphong 31
Rio de Janeiro 31
Chennai 30
Redwood City 30
Rome 30
San Francisco 29
Johannesburg 28
Lappeenranta 28
Norwalk 25
Oxford 25
Phoenix 25
Stockholm 25
Turku 25
Amsterdam 24
Brooklyn 24
Chicago 23
Kent 23
Bologna 22
Elora 22
Lanzhou 22
Vienna 22
Basingstoke 21
Fuzhou 21
Mexico City 21
San Diego 20
Shanghai 20
Falls Church 19
Nuremberg 19
Belo Horizonte 18
Mumbai 18
Poplar 18
Tashkent 18
Totale 19.403
Salva come PNG Salva come JPEG
Nome #
CRISPR/Cas9 mediated knock-out of RUNX2 in melanoma cells 1.328
CRISPR/Cas9 genome editing in melanoma cells: new insight of RUNT domain 1.303
MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines 368
HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity 300
CRISPR/Cas9 as a tool for studying the interactions between viral and cellular proteins 271
New immunogens for the induction of broad spectrum neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) 269
HLA-C presence increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41 248
Broad spectrum neutralizing monoclonal antibodies against HIV-1 elicited by immunizing with fusion complexes 247
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 243
Fusion complexes and CD4-independent Env for the induction of broad spectrum neutralizing antibodies against HIV-1 243
Gα15 in early onset of pancreatic ductal adenocarcinoma 243
HLA-C is necessary for optimal HIV-1 infection of human peripheral blood CD4 lymphocytes 239
HLA-C increases HIV-1 infectivity by interacting with the envelope glycoprotein gp120 238
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 236
Human T-cell leukemia virus HBZ and APH-2 antisense proteins interaction with host factors and their involvement in NF-Kb activation 236
Analysis of colorectal cancers for human cytomegalovirus presence 234
Testing the performance of the imputation of MHC region in large datasets when using different reference panels 233
Fusion complexes and CD4-independene Env for the induction of broad spectrum neutralizing antibodies against HIV-1 232
Expression of HIV-1 NDK m9 env gene in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 231
5. CRISPR/Cas9 for the Study of the Interactions between Viruses and Host 228
Analisi molecolare delle interazioni fra citomegalovirus umano e leucociti 225
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 222
2. CRISPR/Cas9 to study virus-host interactions 219
P-D9 Human Thioesterase 8 and HIV-1 Nef interaction 218
A CRISPR/Cas9 based approach to study the implication of HTLV regulatory proteins in the NF-κB modulation. 218
HLA-C associates with Env and Increases HIV-1 infectivity 217
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 217
A potential role of RUNX2- RUNT domain in modulating the expression of genes involved in bone metastases: an in vitro study with melanoma cells 216
Development of chimeric humanized monoclonal antibodies against HIV-1 215
Molecular characterization of HIV-1 Nef and ACOT8 interaction: insights from in silico structural predictions and in vitro functional assays 215
CRISPR/Cas9 as a tool for the study of the interactions between viruses and host 215
Presence and role of HLA-C in HIV-1 infection 214
HLA-C increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41. 214
Host-virus interactions: HTLV antisense regulatory proteins play a role in the dysregulation of NF-κB pathway 213
Runx2 stimulates neoangiogenesis through the Runt domain in melanoma 211
In silico structural prediction and in vitro functional validation to identify the ACOT8 regions involved in the interaction with HIV-1 Nef 210
Studiare la regione HLA negli esomi 210
HLA-C associates with Env and increases HIV-1 infectivity 208
HTLV-1 and HTLV-2 Tax, HBZ and APH-2 interaction with host factors: their involvement in cellular pathways regulation. 207
Demonstration of the role of HLA-C in HIV-1 infection by siRNA silencing 206
The human T-cell leukemia virus -2 (HTLV-2) antisense protein APH-2 interacts with p65 and inhibits NF-ĸB Tax-2 activation. 206
Expression of HIV-1 NDK m7 and m9 env genes in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 205
Expression of a candidate vaccine for AIDS prevention in transgenic tobacco plants 201
Il ruolo di HLA-C nell'infezione da HIV-1 200
Detection and typing of Human Cytomegalovirus DNA in colorectal cancer 199
The Runt domain of RUNX2 induces the migration of melanoma cells to bone 199
HLA-C expression levels and binding stability to β2m are involved in HIV-1 infectivity 197
Stability and expression levels of HLA-C on the cell membrane modulate HIV-1 infectivity 197
Influenza - Prous Science Integrity 195
Association analysis between HIV-1 Env and HLAC using bimolecular fluorescence complementation 194
Fusion complexes as immunogens for the induction of broad spectrum neutralizing antibodies against HIV-1 193
Association Analysis Between HIV-1 Env and HLA-C Using Bimolecular Fluorescence Complementation 193
Dissection of HLA-C gene region to investigate its association with complex traits 191
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 189
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 188
Unsung hero Robert C. Gallo 187
HTLV ANTISENSE PROTEINS ROLE IN THE NF-κB MODULATION. 187
Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization 186
HIV-1 Env glycoprotein and HLA-C associate and increase HIV-1 infectivity 186
Induction of HIV-1 neutralizing antibodies by fusion complexes 185
New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration 185
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 182
Fusion efficiency between the HIV-1 envelope and the target cell membrane is enhanced by the presence of HLA-C molecules 181
HLA-C and HIV-1: a matter of stability 180
Production of a candidate HIV-1 vaccine in transgenic tobacco plants 179
Expression and purification of recombinant HTLV-2 Tax protein in mammalian cells 179
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 179
Physical activity prevents cartilage degradation: a metabolomics study pinpoints the involvement of vitamin B6 177
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 177
New vaccine strategies for chronic viral infections 175
Induction of human immunodeficiency virus (HIV) neutralizing antibodies with fusion complexes 171
HLA-C increases fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 170
NF-κB activation mediated by HTLV-1 transactivator Tax protein is impaired in TRAF3 knock-out cells. 170
Benzodiazepine use and HIV-associated neurocognitive impairment: which comes first? 170
Vectors derived from antibodies for transfecting substances into cells 168
HTLV deregulation of the NF-κB pathway: an update on tax and antisense proteins role 167
Vectors derived from antibodies for transferring substances into cells 166
HLA-C stability and AIDS progression 166
HLA-C increases HIV-1 infectivity and is associated with gp120 165
HTLV-1 BASIC LEUCIN ZIPPER FACTOR AND ITS HOMOLOGOUS APH-2 IMPAIR NF-κB ACTIVATION MEDIATED BY THE VIRAL ONCOPROTEIN TAX. 165
Involvement of HLA-C binding stability to β2-microglobulin in HIV-1 infection 164
Delayed progression to AIDS in HTLV-I/HIV-1 coinfected intravenous drug users 163
TRAF3 involvement in the NF-κB pathway deregulation mediated by HTLV-1 Tax protein 163
CRISPR/Cas system: an emerging technology in stem cell research 163
ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19 162
Gelsolin activity controls efficient early HIV-1 infection 161
Correction for Parolini et al., "Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity" 161
Expression and purification of recombinant HTLV-II Tax protein in E.Coli and mammalian cells 158
Cell-based vaccination: rationale for the use of cells co-expressing HIV anv gp120 and HLA class I Cw4 molecules for the induction of neutralizing antibodies 156
A fast and reliable method for detecting SNP rs67384697 (Hsa-miR-148a binding site) by a single run of allele-specific real-time PCR 155
Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma 154
TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins 151
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 149
Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression 149
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 148
Fusion complexes and CD4-independent gp120s for the induction of broad spectrum anti HIV-1 neutralizing antibodies 147
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 146
Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2 145
A simple method for human cytomegalovirus (HCMV) DNA quantitation in clinical samples 144
Single-chain antibody fragments for transferring substance 144
Totale 21.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.668
article - articoli 44.588
book - libri 4.646
conference - conferenze 51.619
curatela - curatele 0
other - altro 0
patent - brevetti 1.246
selected - selezionate 0
volume - volumi 1.569
Totale 207.336
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.343 0 338 16 77 47 48 48 99 54 67 146 403
2022/20233.232 253 312 304 571 288 755 27 196 363 40 75 48
2023/20243.664 66 145 153 180 189 2.278 114 96 19 73 201 150
2024/20254.121 268 264 140 623 174 87 297 210 659 283 272 844
2025/202612.381 811 617 971 1.922 2.918 897 1.248 681 1.021 854 176 265
2026/2027537 208 329 0 0 0 0 0 0 0 0 0 0
Totale 32.940